ReviewClinical & translational immunology2025

Engineered iPSC-derived natural killer cells: recent innovations in translational innate anti-cancer immunotherapy.

Jane Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.